关于Monte Rosa Therapeutics：
作为专注于分子胶降解剂（MGD）药物开发的临床阶段生物技术企业，Monte Rosa通过其QuEEN™发现平台整合人工智能化学设计、多样化化合物库与结构生物学技术，致力于开发针对自身免疫性疾病、肿瘤等重大疾病的首创疗法。公司目前有三款研发项目进入临床阶段，并与多家制药巨头在免疫学、肿瘤学领域保持合作。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.